Twitter's popularity continues to grow, and hundreds of physicians are turning to the 140-character platform to connect and share information. Do you tweet?
Twitter's popularity continues to grow, and hundreds of physicians are turning to the 140-character social networking platform to connect and share information.
Celebrity physician Dr. Mehmet Oz tops the list of docs on Twitter with more than 590,000 followers, and well-know primary-care doc and blogger Kevin Pho, MD, is being followed by more than 31,000.
That’s according to TwitterDoctors.net, a directory site featured in a recent The Huffington Post article about docs and Twitter. According to the article, some 1,300 docs have added themselves to the directory. The real number of Twittering docs could be far greater.
Many physicians turn to the social networking tool to share relevant links and news items, and promote themselves or their practice. Some say it’s where the patients are, so it’s where physicians should be as well, while others find it to be a quick, easy way to connect with colleagues. Very few are guilty of mixing medical advice with social networking.
So, do you tweet?
Vote here and tell us in the comments your thoughts on Twitter.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.